Emma Heming Willis, the author and advocate, has recently announced a new philanthropic initiative dedicated to supporting research and caregivers of those affected by frontotemporal dementia (FTD). This announcement came during her acceptance of the Susan Newhouse & Si Newhouse Award of Hope at the Association for Frontotemporal Degeneration (AFTD) Hope Rising Benefit held in New York City on March 12, 2023.
:max_bytes(150000):strip_icc():format(jpeg)/bruce-willis-wife-emma-heming-main-122324-c1c01c147a7b4036b754aba8708532ad.jpg)
The newly established Emma & Bruce Willis Fund is designed to elevate understanding of frontotemporal dementia. Governed by the Entertainment Industry Foundation, the fund aims to enhance awareness, finance promising scientific research, and provide essential support for caregivers. This effort emerges from a deeply personal connection, as Bruce Willis, Emma’s husband, was diagnosed with FTD in late 2022 at the age of 67.

During her heartfelt speech, Heming Willis reflected on her experiences in navigating the complexities of FTD alongside her family. She said, “This journey has opened my eyes to the realities so many families face when a loved one is living with frontotemporal dementia.” Her commitment to the cause is evident, with a clear focus on the dual support of advancing research alongside aiding caregivers who bear significant emotional and physical burdens daily.

Emma’s hope is that the new fund will not only provide financial assistance but also foster a sense of community for families affected by FTD. “Through this fund, my hope is to help deepen understanding of FTD and ensure families facing it feel seen, supported, and less alone,” she explained. The emotional weight of her words rests on the shared experience of families dealing with such challenging diagnoses.
The Willis family’s journey began publicly with the revelation of Bruce’s aphasia diagnosis in March 2022, which was later narrowed down to frontotemporal dementia in February 2023. This diagnosis has prompted an increased public interest in FTD, a group of brain disorders characterised by degeneration of the frontal and temporal lobes. This condition is known to cause serious speech problems, personality changes, and motor skill difficulties.
In tandem with her advocacy work, Heming Willis has compiled her own experiences into a book titled “The Unexpected Journey.” The publication aims to serve as a supportive guide for others grappling with similar challenges. In conversation, she remarked on her evolving role as a caregiver, reflecting on the isolation she felt in the early stages of Bruce’s diagnosis. “In the beginning, I was very isolated, and it felt like what was happening was only happening to us. Over time, I realised it would be beneficial to talk about it and raise awareness,” she noted.
Her insights extend beyond her own narrative. Heming Willis emphasised the importance of early diagnosis and accessing clinical trials. She conveyed her desire for her book to function as a resource that addresses the emotional and practical difficulties inherent in caregiving. “I wrote the book that I wish someone had handed me on the day we received the diagnosis,” she stated, highlighting the rarity of support for caregivers navigating similar paths.
Reflecting on her husband’s legacy and character, she added, “Bruce has always led with generosity and heart, and I know he would be proud to see this effort helping families facing this disease.” This philanthropic endeavour not only aims to facilitate research but also seeks to cultivate a nurturing environment for those who are often left feeling alone in their struggles.
As the Willis family continues to navigate this challenging chapter, their commitment to raising awareness regarding frontotemporal dementia stands as both an inspiration and a beacon of hope for other families enduring similar experiences. Their shared journey illustrates the profound impact of love and support amidst the challenges of neurodegenerative diseases, reinforcing the idea that no one should face such trials alone.
